Multidisciplinary Breast Center, School of Medicine,Catholic University of the "Sacred Heart", Rome, Italy.
Eur Rev Med Pharmacol Sci. 2012 Jul;16(7):966-71.
Breast conserving surgery (BCS) combined with postoperative radiotherapy has become the gold standard of locoregional treatment for the majority of patients with early-stage breast cancer, offering equivalent survival and improved body image and lifestyle scores as compared to mastectomy. In an attempt to optimize the oncologic safety and cosmetic results of BCS, oncoplastic procedures (OPP) have been introduced in recent years combining the best principles of surgical oncology with those of plastic surgery. However, even with the use of OPP, cosmetic outcomes may result unsatisfying when a large volume of parenchyma has to be removed, particularly in small-medium size breasts.
The aim of this article is to report our preliminary results with the use of oxidized regenerate cellulose (ORC) (Tabotamp fibrillar, Johnson & Johnson; Ethicon, USA) as an agent to prevent cosmetic defects in patients undergoing OPP for breast cancer and to analyze the technical refinements that can enhance its efficacy in optimizing cosmetic defects.
Different OPP are selected based on the location and size of the tumor as well as volume and shape of the breast. After excision of the tumor, glandular flaps are created by dissection of the residual parenchyma from the pectoralis and serratus muscles and from the skin. After careful haemostasis, five layers of ORC are positioned on the pectoralis major in the residual cavity and covered by advancement of the glandular flaps. Two additional layers of ORC are positioned above the flaps and covered by cutaneous-subcutaenous flaps.
The use of ORC after OPP has shown promising preliminary results, indicating a good tolerability and positive effects on cosmesis.
This simple and reliable surgical technique may allow not only to reduce the rate of post-operative bleeding and infection at the surgical site but also to improve cosmetic results.
保乳手术(BCS)联合术后放疗已成为大多数早期乳腺癌患者局部区域治疗的金标准,与乳房切除术相比,其提供了等效的生存和改善的身体形象和生活质量评分。为了优化 BCS 的肿瘤安全性和美容效果,近年来引入了肿瘤整形手术(OPP),将外科肿瘤学的最佳原则与整形外科学的原则相结合。然而,即使使用 OPP,当必须切除大量实质组织时,美容效果可能仍不尽如人意,特别是在中小乳房中。
本文旨在报告我们使用氧化再生纤维素(ORC)(Johnson & Johnson 的 Tabotamp 纤维状;Ethicon,美国)预防接受乳腺癌 OPP 患者美容缺陷的初步结果,并分析可增强其优化美容缺陷功效的技术改进。
根据肿瘤的位置和大小以及乳房的体积和形状选择不同的 OPP。切除肿瘤后,通过从胸肌和胸肌筋膜以及皮肤中分离剩余实质组织来创建腺体皮瓣。仔细止血后,将 5 层 ORC 置于胸大肌的残余腔中,并通过推进腺体皮瓣覆盖。将另外 2 层 ORC 置于皮瓣上方,并覆盖皮肤-皮下皮瓣。
OPP 后使用 ORC 显示出有希望的初步结果,表明其具有良好的耐受性和对美容效果的积极影响。
这种简单可靠的手术技术不仅可以降低手术部位的术后出血和感染率,还可以改善美容效果。